Dr. Mauro Antonio Dispagna, MD

  • Philadelphia, PA
  • Urologist
NPI1528642626PAC ID8325447501
Part D claims, 2024
326
Publications
5
Hospital affiliations
1
Industry payments
$6,046
Medical group
1
Practice address
111 South 11th Street, Philadelphia, PA 19107
Practice phone
Call (215) 955-6000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Thomas Jefferson University Hospital

Hospital · Philadelphia, Pennsylvania

Find Dr. Dispagna's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mauro Antonio Dispagna is a urologist in Philadelphia, Pennsylvania

Dr. Dispagna practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

Dr. Dispagna's NPI, 1528642626, was assigned on May 6, 2021. Dr. Dispagna holds Pennsylvania license MT222952.

NPI and contact details
Medicare PAC ID
8325447501
NPI enumeration date
May 6, 2021
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(215) 955-6000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mauro Antonio Dispagna practices at 2 locations in Philadelphia, Pennsylvania

Dr. Dispagna's primary practice is Thomas Jefferson University Hospital, at 111 South 11th Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 955-6000. The NPI Registry lists Dr. Dispagna's practice address as 3400 Spruce St, Philadelphia, PA 19104.

  • Thomas Jefferson University HospitalPrimary
    111 South 11th Street, Philadelphia, PA 19107 · Philadelphia CountyPhone(215) 955-6000
  • NPI Registry address
    3400 Spruce St, Philadelphia, PA 19104 · Philadelphia CountyPhone(215) 955-1000

Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; and Dmand AI Practice Data

Dr. Mauro Antonio Dispagna is affiliated with 1 site of care and 1 medical group

Dr. Dispagna's primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University. The medical group on file is Orlando Health Medical Group.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mauro Antonio Dispagna's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dispagna practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Thomas Jefferson University HospitalAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Dispagna practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Thomas Jefferson University and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mauro Antonio Dispagna is one of 562 urologists in Pennsylvania

Urology is Dr. Dispagna's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Dispagna is licensed in Pennsylvania.

Specialties and state licenses

  • Urology, PennsylvaniaPrimaryLicense MT222952 · taxonomy 208800000X

Urologists near Dr. Dispagna

Counts of urologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mauro Antonio Dispagna's patients have a median age of 87

Across all payers, Dmand AI patient panel data puts Dr. Dispagna's median patient age at 87, with 0% women.

Dr. Dispagna's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 87

Patient panel by sex, all payers

  • Women0%
  • Men100%

Source: Dmand AI Patient Panel Data

Dr. Mauro Antonio Dispagna wrote 326 Medicare Part D claims in 2024

In 2024, Dr. Dispagna wrote 326 Medicare Part D claims for 150 patients. 82% of them were for generic drugs. CMS names the drug for 252 of them, across 13 drugs with 11 or more claims each, at $35,961 in total drug cost. In 2023, CMS named 150 claims across 7 drugs.

Part D claims, 2024326
Drugs named by CMS13
Total drug cost$35,961
Part D patients150

Dr. Dispagna's Part D claims by kind of drug, 2024

  • Generic267 claims82%
  • Brand-name and other59 claims18%

Dr. Dispagna's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Dispagna's Part D claims, 2024

  • Antibiotics33%106 of 326 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1502024: 25268%

Drugs named by CMS: 13 in 2024, 7 in 2023.

See all prescribing by Dr. Dispagna

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Mauro Antonio Dispagna takes part in Medicare

Dr. Dispagna accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find urologists like Dr. Dispagna by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mauro Antonio Dispagna has 5 publications on record

Dmand AI links 5 papers to Dr. Dispagna, published from 2017 to 2024. 2024 was the busiest year, with 2. Dr. Dispagna's most frequent co-authors are Steven Richard Smith, MD, Gennady Bratslavsky, MD and Timothy Karl Byler, MD.

Papers5
Years published2017 to 2024

Dr. Dispagna's papers by year, 2017 to 2024

Dr. Dispagna's most frequent co-authors

Recent publications by Dr. Dispagna

See all 5 publications and co-authors

See who Dr. Dispagna researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Dispagna works with, so you can find a warm path to the right urologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mauro Antonio Dispagna received $6,046 in industry payments from 2021 to 2025

CMS Open Payments shows 86 general payments to Dr. Dispagna from 18 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 85% of the total. Medtronic, Inc. paid the most, $1,682.

General payments to Dr. Dispagna by program year, 2021 to 2025

General payments to Dr. Dispagna by kind, 2021 to 2025

$6Kin total
  • Food and beverage$5,14785%
  • Travel and lodging$60510%
  • Education$2945%

Companies that paid Dr. Dispagna the most, 2021 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Dispagna

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Mauro Antonio Dispagna's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDmand AI Practice Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mauro Antonio Dispagna

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mauro Antonio Dispagna's NPI number?

Dr. Mauro Antonio Dispagna's NPI number is 1528642626. It was assigned on May 6, 2021, and it is active in the NPI Registry.

What kind of doctor is Dr. Mauro Antonio Dispagna?

Dr. Mauro Antonio Dispagna is a urologist in Philadelphia, Pennsylvania. The primary specialty in the NPI Registry is Urology Physician (taxonomy code 208800000X).

Where does Dr. Mauro Antonio Dispagna practice?

Dr. Dispagna practices at 111 South 11th Street, Philadelphia, PA 19107. Dr. Dispagna also practices at 3400 Spruce St, Philadelphia, PA 19104. Dr. Dispagna's primary practice is Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, part of Thomas Jefferson University.

What is Dr. Mauro Antonio Dispagna's office phone number?

The practice phone on file for Dr. Dispagna is (215) 955-6000.

What is Dr. Mauro Antonio Dispagna's medical license number?

Dr. Dispagna holds Pennsylvania license MT222952.

Which hospitals is Dr. Mauro Antonio Dispagna affiliated with?

Dr. Dispagna practices at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.

What medical group is Dr. Mauro Antonio Dispagna part of?

Dr. Dispagna is linked to Orlando Health Medical Group.

Does Dr. Mauro Antonio Dispagna accept Medicare?

Yes. CMS lists Dr. Dispagna as accepting Medicare assignment.

What drugs does Dr. Mauro Antonio Dispagna prescribe most?

In 2024 Medicare Part D data, Dr. Dispagna's most prescribed drugs by claims were Tamsulosin HCl, Amoxicillin-Clavulanate Potass and Gemtesa.

Has Dr. Mauro Antonio Dispagna received payments from drug or device companies?

CMS Open Payments shows $6,046 in general payments to Dr. Dispagna from 18 companies from 2021 to 2025. The largest total came from Medtronic, Inc.

Show 3 more questionsShow fewer questions

How long has Dr. Mauro Antonio Dispagna been practicing?

Dr. Dispagna's NPI was assigned in 2021.

Does Dr. Mauro Antonio Dispagna do research?

Dmand AI links 5 publications to Dr. Dispagna, published from 2017 to 2024.

Who does Dr. Mauro Antonio Dispagna publish with?

Dr. Dispagna's most frequent co-authors are Steven Richard Smith, MD (2 shared papers), Gennady Bratslavsky, MD (1 shared paper) and Timothy Karl Byler, MD (1 shared paper).

Selling to urology practices?

See urologists in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)